Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men von Yee, Ka Lai, McCrea, Jacqueline, Panebianco, Deborah, Liu, Wen, Lewis, Nicole, Cabalu, Tamara, Ramael, Steven, Wrishko, Rebecca E.

Volltext

Tadalafil pharmacokinetics in healthy subjects von Forgue, S. Thomas, Patterson, Beverley E., Bedding, Alun W., Payne, Christopher D., Phillips, Diane L., Wrishko, Rebecca E., Mitchell, Malcolm I.

Volltext

Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects von Wrishko, Rebecca E., Dingemanse, Jasper, Yu, Albert, Darstein, Christelle, Phillips, Diane L., Mitchell, Malcolm I.

Volltext

Predicted Bezlotoxumab Exposure in Patients Who Have Received a Hematopoietic Stem Cell Transplant von de Almeida, Camila, Wong, Michael, Kleijn, Huub Jan, Wrishko, Rebecca E.

Volltext

Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy von Riesmeyer, Jeffrey S., Salazar, Daniel E., Weerakkody, Govinda J., Ni, Lan, Wrishko, Rebecca E., Ernest II, C. Steven, Luo, Junxiang, Li, Ying G., Small, David S., Rohatagi, Shashank, Macias, William L.

Volltext

A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia von Winchell, Gregory, de Greef, Rik, Ouerdani, Aziz, Fauchet, Floris, Wrishko, Rebecca E, Mangin, Eric, Bruno, Christopher, Waskin, Hetty

Volltext

Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile Infection von Yee, Ka Lai, Kleijn, Huub Jan, Kerbusch, Thomas, Matthews, Randolph P, Dorr, Mary Beth, Garey, Kevin W, Wrishko, Rebecca E

Volltext

Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics von Forgue, S. Thomas, Phillips, Diane L., Bedding, Alun W., Payne, Christopher D., Jewell, Hayley, Patterson, Beverley E., Wrishko, Rebecca E., Mitchell, Malcolm I.

Volltext

A time-to-event analysis of the exposure–response relationship for bezlotoxumab concentrations and CDI recurrence von Yee, Ka Lai, Kleijn, Huub Jan, Zajic, Stefan, Dorr, Mary Beth, Wrishko, Rebecca E.

Volltext

Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects von Wrishko, Rebecca E., McCrea, Jacqueline B., Yee, Ka Lai, Liu, Wen, Panebianco, Deborah, Mangin, Eric, Chakravarthy, Manu, Martinez-Cantarin, Maria P., Kraft, Walter K.

Volltext

Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment von Min, K Chris, Lasseter, Kenneth C, Marbury, Thomas C, Wrishko, Rebecca E, Hanley, William D, Wolford, Dennis G, Udo de Haes, Joanna, Reitmann, Christina, Gutstein, David E

Volltext

Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects von Wrishko, Rebecca E., McCrea, Jacqueline B., Yee, Ka Lai, Liu, Wen, Panebianco, Deborah, Mangin, Eric, Chakravarthy, Manu, Martinez-Cantarin, Maria P., Kraft, Walter K.

Volltext

Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38 von Wrishko, Rebecca E., Ernest II, C. Steven, Small, David S., Li, Ying G., Weerakkody, Govinda J., Riesmeyer, Jeffrey R., Macias, William L., Rohatagi, Shashank, Salazar, Daniel E., Antman, Elliott M., Wiviott, Stephen D., Braunwald, Eugene, Ni, Lan

Volltext

Assessment of Bezlotoxumab Immunogenicity von Montgomery, Diana L., Matthews, Randolph P., Yee, Ka Lai, Tobias, Lori M., Dorr, Mary Beth, Wrishko, Rebecca E.

Volltext

Vancomycin pharmacokinetics and bayesian estimation in pediatric patients von WRISHKO, Rebecca E, LEVINE, Marc, KHOO, Dominique, ABBOTT, Phyllis, HAMILTON, Don

Volltext

CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD von Trzepacz, Paula T, Williams, David W, Feldman, Peter D, Wrishko, Rebecca E, Witcher, Jennifer W, Buitelaar, Jan K

Volltext

Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease von Ernest, C. Steven, Small, David S., Rohatagi, Shashank, Salazar, Daniel E., Wallentin, Lars, Winters, Kenneth J., Wrishko, Rebecca E.

Volltext

Prediction of Prasugrel Active Metabolite Concentrations From 2 Downstream Inactive Metabolite Concentrations Using Multilinear Regression Analysis von Ernest II, C. Steven, Heathman, Michael A., Wrishko, Rebecca E.

Volltext

Effect of Age on the Pharmacokinetics and Pharmacodynamics of Prasugrel during Multiple Dosing: An Open-Label, Single-Sequence, Clinical Trial von Small, David S., Wrishko, Rebecca E., Ernest, C. Steven, Ni, Lan, Winters, Kenneth J., Farid, Nagy A., Li, Ying G., Salazar, Daniel E., Payne, Christopher D.

Volltext

Model-Informed Drug Development Supporting Late-Stage Drug Development and Regulatory Approval in Japan: A Case Study of Posaconazole von Wrishko, Rebecca E.

Volltext